FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387133037> ?p ?o ?g. }

• W4387133037 abstract "Abstract Background In contrast to evidence for interventions supporting victim/survivors of domestic violence and abuse (DVA), the effectiveness of perpetrator programmes for reduction of abuse is uncertain. This study aims to estimate the effectiveness and cost-effectiveness of a perpetrator programme for men. Methods Pragmatic two-group individually randomised controlled trial (RCT) with embedded process and economic evaluation. Five centres in southwest England and South Wales aim to recruit 316 (reduced from original target of 366) male domestic abuse perpetrators. These will be randomised 2:1 to a community-based domestic abuse perpetrator programme (DAPP) or usual care comparator with 12-month follow-up. Female partners/ex-partners will be invited to join the study. The intervention for men comprises 23 weekly sessions of a group programme delivered in voluntary sector domestic abuse services. The intervention for female partners/ex-partners is one-to-one support from a safety worker. Men allocated to usual care receive no intervention; however, they are free to access other services. Their partners/ex-partners will be signposted to support services. Data is collected at baseline, and 4, 8 and 12 months’ follow-up. The primary outcome is men’s self-reported abusive behaviour measured by the Abusive Behaviour Inventory (ABI-29) at 12 months. Secondary measures include physical and mental health status and resource use alongside the abuse measure ABI (ABI-R) for partners/ex-partners and criminal justice contact for men. A mixed methods process evaluation and qualitative study will explore mechanisms of effectiveness, judge fidelity to the intervention model using interviews and group observations. The economic evaluation, over a 1-year time horizon from three perspectives (health and social care, public sector and society), will employ a cost-consequences framework reporting costs alongside economic outcomes (Quality-Adjusted Life Years derived from EQ-5D-5L, SF-12 and CHU-9D, and ICECAP-A) as well as the primary and other secondary outcomes. Discussion This trial will provide evidence of the (cost)effectiveness of a DAPP. The embedded process evaluation will further insights in the experiences and contexts of participants and their journey through a perpetrator programme, and the study will seek to address the omission in other studies of economic evaluations. Trial registration ISRCTN15804282, April 1, 2019" @default.
• W4387133037 created "2023-09-29" @default.
• W4387133037 creator A5024533269 @default.
• W4387133037 creator A5032167190 @default.
• W4387133037 creator A5043356563 @default.
• W4387133037 creator A5047649313 @default.
• W4387133037 creator A5050466847 @default.
• W4387133037 creator A5050594691 @default.
• W4387133037 creator A5054449436 @default.
• W4387133037 creator A5055249430 @default.
• W4387133037 creator A5060462818 @default.
• W4387133037 creator A5064056110 @default.
• W4387133037 creator A5068550918 @default.
• W4387133037 creator A5069596093 @default.
• W4387133037 creator A5079608578 @default.
• W4387133037 creator A5080752448 @default.
• W4387133037 creator A5086222012 @default.
• W4387133037 date "2023-09-28" @default.
• W4387133037 modified "2023-10-03" @default.
• W4387133037 title "The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial" @default.
• W4387133037 cites W1487151488 @default.
• W4387133037 cites W1579071987 @default.
• W4387133037 cites W1969519267 @default.
• W4387133037 cites W1970848231 @default.
• W4387133037 cites W1990166011 @default.
• W4387133037 cites W2011644590 @default.
• W4387133037 cites W2017857669 @default.
• W4387133037 cites W2018903630 @default.
• W4387133037 cites W2018995282 @default.
• W4387133037 cites W2019947910 @default.
• W4387133037 cites W2037193487 @default.
• W4387133037 cites W2043705607 @default.
• W4387133037 cites W2054317075 @default.
• W4387133037 cites W2064451180 @default.
• W4387133037 cites W2065725628 @default.
• W4387133037 cites W2081234327 @default.
• W4387133037 cites W2085121913 @default.
• W4387133037 cites W2092052931 @default.
• W4387133037 cites W2093274439 @default.
• W4387133037 cites W2097195345 @default.
• W4387133037 cites W2099274262 @default.
• W4387133037 cites W2100429511 @default.
• W4387133037 cites W2104871900 @default.
• W4387133037 cites W2110608362 @default.
• W4387133037 cites W2110775452 @default.
• W4387133037 cites W2117076727 @default.
• W4387133037 cites W2118249259 @default.
• W4387133037 cites W2132322340 @default.
• W4387133037 cites W2153491752 @default.
• W4387133037 cites W2162544110 @default.
• W4387133037 cites W2171506138 @default.
• W4387133037 cites W2172151487 @default.
• W4387133037 cites W2175831798 @default.
• W4387133037 cites W2271506999 @default.
• W4387133037 cites W2375701190 @default.
• W4387133037 cites W2468117220 @default.
• W4387133037 cites W2551456563 @default.
• W4387133037 cites W2580476391 @default.
• W4387133037 cites W2621668336 @default.
• W4387133037 cites W2731622813 @default.
• W4387133037 cites W2913092503 @default.
• W4387133037 cites W2923214679 @default.
• W4387133037 cites W2944434778 @default.
• W4387133037 cites W2947368437 @default.
• W4387133037 cites W2967765847 @default.
• W4387133037 cites W2968316645 @default.
• W4387133037 cites W3005827022 @default.
• W4387133037 cites W3194472989 @default.
• W4387133037 cites W4241620769 @default.
• W4387133037 cites W4324098440 @default.
• W4387133037 cites W4378470578 @default.
• W4387133037 doi "https://doi.org/10.1186/s13063-023-07612-6" @default.
• W4387133037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37770906" @default.
• W4387133037 hasPublicationYear "2023" @default.
• W4387133037 type Work @default.
• W4387133037 citedByCount "0" @default.
• W4387133037 crossrefType "journal-article" @default.
• W4387133037 hasAuthorship W4387133037A5024533269 @default.
• W4387133037 hasAuthorship W4387133037A5032167190 @default.
• W4387133037 hasAuthorship W4387133037A5043356563 @default.
• W4387133037 hasAuthorship W4387133037A5047649313 @default.
• W4387133037 hasAuthorship W4387133037A5050466847 @default.
• W4387133037 hasAuthorship W4387133037A5050594691 @default.
• W4387133037 hasAuthorship W4387133037A5054449436 @default.
• W4387133037 hasAuthorship W4387133037A5055249430 @default.
• W4387133037 hasAuthorship W4387133037A5060462818 @default.
• W4387133037 hasAuthorship W4387133037A5064056110 @default.
• W4387133037 hasAuthorship W4387133037A5068550918 @default.
• W4387133037 hasAuthorship W4387133037A5069596093 @default.
• W4387133037 hasAuthorship W4387133037A5079608578 @default.
• W4387133037 hasAuthorship W4387133037A5080752448 @default.
• W4387133037 hasAuthorship W4387133037A5086222012 @default.
• W4387133037 hasBestOaLocation W43871330371 @default.
• W4387133037 hasConcept C118552586 @default.
• W4387133037 hasConcept C134362201 @default.
• W4387133037 hasConcept C141071460 @default.
• W4387133037 hasConcept C159110408 @default.
• W4387133037 hasConcept C168563851 @default.
• W4387133037 hasConcept C27415008 @default.
• W4387133037 hasConcept C2780665704 @default.

• next